Phase Bioscience, Inc. Announces Positive Clinical Results with its Once Weekly GLP-1 Analogue, Glymera™ for the Treatment of Hyperglycemia in Patients with Type 2 Diabetes
11/15/2011 7:25:19 AM
More...
|
Craig Rosen, Ph.D., Biopharmaceutical Development Expert, Joins Phase Bioscience, Inc. as Executive Chairman
10/9/2008 9:30:55 AM
More...
|
Phase Bioscience, Inc. Licenses Key Patent Portfolio, Adds Expert in Protein Engineering IP Protection
9/23/2008 8:24:10 AM
More...
|
Leading Protein Engineering Executive Joins Phase Bioscience, Inc. as CEO
4/15/2008 8:29:12 AM
More...
|
Phase Bioscience, Inc. Secures Funding Resources and Laboratory Space
3/12/2008 9:51:23 AM
More...
|
Phase Bioscience, Inc. Announces New Collaboration with Centocor Research And Development, Inc.
1/3/2008 9:24:32 AM
More...
|
Phase Bioscience, Inc. Announces Series B Investment from Johnson & Johnson Development Corporation, Fletcher Spaght Ventures and Hatteras Venture Partners
10/24/2007 12:53:20 PM
More...
|
Phase Bioscience, Inc. Strengthens Management Team
4/10/2007 12:28:37 PM
More...
|
Phase Bioscience, Inc. Announces Investment From Johnson & Johnson (JNJ) Development Corporation
1/4/2007 10:58:34 AM
More...
|
Phase Bioscience, Inc. Announces Licensing Agreement With Duke University
11/8/2006 11:07:41 AM
More...
|
|